Table of Content
"1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 36
1.2.2 MARKETS COVERED 37
FIGURE 1 APAC INFUSION PUMPS MARKET SEGMENTATION 37
1.2.3 YEARS CONSIDERED FOR THE STUDY 38
1.3 CURRENCY 38
1.4 STAKEHOLDERS 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
FIGURE 2 APAC INFUSION PUMPS MARKET: RESEARCH DESIGN 40
2.1.1 SECONDARY RESEARCH 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 42
FIGURE 3 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE
AND DEMAND-SIDE PARTICIPANTS 46
2.2 MARKET SIZE ESTIMATION 46
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 47
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 47
FIGURE 8 DEMAND-SIDE ANALYSIS: APAC INFUSION PUMPS MARKET 48
FIGURE 9 TOP-DOWN APPROACH 49
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE APAC INFUSION PUMPS MARKET (2022–2027) 50
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 52
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 52
2.4 MARKET SHARE ANALYSIS 53
2.5 ASSUMPTIONS FOR THE STUDY 53
2.6 RISK ASSESSMENT 54
TABLE 1 RISK ASSESSMENT: INFUSION PUMPS MARKET 54
2.7 LIMITATIONS 54
2.7.1 METHODOLOGY-RELATED LIMITATIONS 54
2.7.2 SCOPE-RELATED LIMITATIONS 54
3 EXECUTIVE SUMMARY 55
FIGURE 13 APAC INFUSION PUMPS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 55
FIGURE 14 APAC INFUSION PUMPS ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2022 VS. 2027 (USD MILLION) 56
FIGURE 15 APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 56
FIGURE 16 APAC INFUSION PUMPS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 57
FIGURE 17 APAC INFUSION PUMPS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 58
4 PREMIUM INSIGHTS 59
4.1 APAC INFUSION PUMPS MARKET OVERVIEW 59
FIGURE 18 THE GROWING INCIDENCE OF CHRONIC DISEASES IS A KEY FACTOR DRIVING THE MARKET GROWTH 59
4.2 ASIA PACIFIC: INFUSION PUMPS MARKET, BY DEVICE & COUNTRY 60
FIGURE 19 THE VOLUMETRIC INFUSION PUMPS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2021 60
4.3 APAC INFUSION PUMPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 20 CHINA IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 61
4.4 APAC INFUSION PUMPS MARKET, BY REGION (2020–2027) 62
FIGURE 21 CHINA TO DOMINATE THE APAC INFUSION PUMPS MARKET DURING THE FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 MARKET DYNAMICS 63
FIGURE 22 APAC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.1.1 MARKET DRIVERS 64
5.1.1.1 Rising demand for ambulatory infusion pumps in homecare settings 64
5.1.1.2 Rapid growth in the geriatric population and the subsequent rise in chronic diseases 64
FIGURE 23 ASIAN CANCER INCIDENCE, 2020–2040 65
FIGURE 24 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 66
5.1.1.3 Increasing adoption of enteral feeding pumps due to a surge in pre-term births 67
5.1.1.4 Rising number of surgical procedures performed worldwide 67
5.1.1.5 Increasing number of ICU beds in countries with a high prevalence of COVID-19 68
TABLE 2 MARKET DRIVERS: IMPACT ANALYSIS 68
5.1.2 MARKET RESTRAINTS 69
5.1.2.1 Product recalls 69
TABLE 3 INDICATIVE LIST OF PRODUCT RECALLS FOR INFUSION PUMPS
(2017–MARCH 2022) 69
5.1.2.2 Stringent regulatory requirements for the approval of new products 70
5.1.2.3 Increasing adoption of refurbished & rented infusion pumps 70
TABLE 4 MARKET RESTRAINTS: IMPACT ANALYSIS 71
5.1.3 MARKET OPPORTUNITIES 71
5.1.3.1 High growth opportunities in emerging markets 71
TABLE 5 RISING INCOME LEVELS IN EMERGING COUNTRIES 72
5.1.3.2 Growing adoption of specialty infusion systems 72
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS 73
5.1.4 MARKET CHALLENGES 73
5.1.4.1 Increasing incidence of medication errors and inadequate wireless connectivity in most hospitals 73
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS 73
5.2 INDUSTRY TRENDS 74
5.2.1 SMART PUMP-EMR INTEROPERABILITY 74
TABLE 8 RECENT DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY 74
5.2.2 GROWING FOCUS ON THE DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 75
TABLE 9 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 75
5.2.3 GROWING FOCUS ON SPECIALTY PUMPS WITH ADDITIONAL
ADVANCED FEATURES 76
5.3 KEY CONFERENCES & EVENTS IN 2022-2023 77
TABLE 10 APAC INFUSION PUMPS MARKET: DETAILED LIST OF
CONFERENCES & EVENTS 77
5.4 PRICING ANALYSIS 77
TABLE 11 ASP OF INFUSION PUMP DEVICES 78
TABLE 12 ASP OF NON-DEDICATED ACCESSORIES & CONSUMABLES 78
5.5 VALUE CHAIN ANALYSIS 78
FIGURE 25 APAC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 79
5.6 SUPPLY CHAIN ANALYSIS 79
FIGURE 26 APAC INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS 80
5.7 ECOSYSTEM MARKET MAP 80
FIGURE 27 INFUSION PUMPS MARKET: ECOSYSTEM MARKET MAP 81
5.8 PORTER’S FIVE FORCES ANALYSIS 81
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 82
5.8.1 THREAT FROM NEW ENTRANTS 82
5.8.2 THREAT FROM SUBSTITUTES 83
5.8.3 BARGAINING POWER OF SUPPLIERS 83
5.8.4 BARGAINING POWER OF BUYERS 83
5.8.5 COMPETITIVE RIVALRY 84
5.9 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 14 ASIA-PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
5.10 REGULATORY ANALYSIS 84
5.10.1 APAC 85
5.10.1.1 Japan 85
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 85
5.10.1.2 China 85
TABLE 16 CHINA: CFDA CLASSIFICATION OF MEDICAL DEVICES 86
5.10.1.3 India 86
5.11 IMPACT OF COVID-19 ON THE APAC INFUSION PUMPS MARKET 87
5.12 PATENT ANALYSIS 88
5.12.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 88
FIGURE 28 PATENT PUBLICATION TRENDS (2011–MARCH 2022) 88
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFUSION PUMP PATENTS (JANUARY 2011–MARCH 2022) 89
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMP PATENTS (JANUARY 2011–MARCH 2022) 90
TABLE 17 LIST OF PATENTS/PATENT APPLICATIONS IN THE ORGAN PRESERVATION MARKET, 2021–2022 90
5.13 TECHNOLOGY ANALYSIS 92
5.13.1 KEY TECHNOLOGIES 92
5.13.1.1 Flow generation 92
5.13.1.2 Flow control 92
5.13.2 ADJACENT TECHNOLOGIES 92
5.13.2.1 Embedded software 92
5.13.2.2 Sensing technology 93
5.13.3 COMPLEMENTARY TECHNOLOGIES 93
5.13.3.1 Dose error reduction systems 93
5.13.3.2 Wireless connectivity 93
5.14 TRADE ANALYSIS 94
TABLE 18 AISA PACIFIC EXPORT DATA OF INFUSION PUMPS FOR 2020 94
TABLE 19 TRADE DATA ANALYSIS OF INFUSION PUMP IMPORTS TO INDIA 95
6 APAC INFUSION PUMPS MARKET, BY PRODUCT 97
6.1 INTRODUCTION 98
TABLE 20 APAC INFUSION PUMPS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98
6.2 IMPACT OF COVID-19 ON THE APAC INFUSION PUMPS MARKET, BY PRODUCT 98
6.3 ACCESSORIES AND CONSUMABLES 99
TABLE 21 KEY INFUSION PUMP ACCESSORIES & CONSUMABLES AVAILABLE
IN THE MARKET 99
TABLE 22 APAC INFUSION PUMP ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 23 APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY COUNTRY 2020–2027 (USD MILLION) 101
6.3.1 DEDICATED ACCESSORIES AND CONSUMABLES 101
TABLE 24 DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2020–2027 (USD MILLION) 102
TABLE 25 DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.3.1.1 Volumetric infusion pumps 103
6.3.1.1.1 Increasing adoption of volumetric infusion pumps to deliver large volumes of medication and nutrients to patients in hospitals drives the market growth 103
TABLE 26 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 103
6.3.1.2 Insulin pumps 103
6.3.1.2.1 The rising demand for insulin pumps for the increasing number of insulin-dependent diabetic patients supports market growth 103
TABLE 27 IDF SOUTH-EAST ASIA AND WESTERN PACIFIC REGION AT A GLANCE, 2019 104
TABLE 28 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INSULIN PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.3.1.3 Enteral infusion pumps 105
6.3.1.3.1 Delivery of precise and consistent infusion results in higher adoption of enteral infusion pumps 105
TABLE 29 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR ENTERAL INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 105
6.3.1.4 Syringe infusion pumps 106
6.3.1.4.1 Adoption of dedicated syringe pump accessories is high in developed countries—a key factor driving the market growth 106
TABLE 30 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR SYRINGE INFUSION PUMPS, BY REGION, 2020–2027 (USD MILLION) 106
6.3.1.5 Ambulatory infusion pumps 107
6.3.1.5.1 The growing home healthcare market fuels the adoption of dedicated ambulatory infusion pumps & accessories 107
TABLE 31 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR AMBULATORY INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 107
6.3.1.6 PCA pumps 108
6.3.1.6.1 Adoption of PCA pumps is driven by the increasing demand for pain management treatment 108
TABLE 32 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR PCA PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 108
6.3.1.7 Implantable infusion pumps 109
6.3.1.7.1 Dedicated infusion pump accessories are preferred due to their compatibility with the implantable infusion pumps 109
TABLE 33 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2020–2027 (USD MILLION) 109
6.3.2 NON-DEDICATED ACCESSORIES AND CONSUMABLES 110
TABLE 34 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 35 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY 2020–2027 (USD MILLION) 111
6.3.2.1 Infusion catheters 111
6.3.2.1.1 Recurrent use of infusion catheters to drive the market growth 111
TABLE 36 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2020–2027 (USD MILLION) 111
6.3.2.2 IV/Administration sets 112
6.3.2.2.1 IV/administration sets are the primary requirement for infusion pumps—a key factor driving market growth 112
TABLE 37 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IV/ADMINISTRATION SETS, BY COUNTRY, 2020–2027 (USD MILLION) 112
6.3.2.3 Needleless connectors 113
6.3.2.3.1 Needleless connectors reduce bloodstream infection risks 113
TABLE 38 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY 2020–2027 (USD MILLION) 113
6.3.2.4 Cannulas 114
6.3.2.4.1 Cannulas are preferred over steel needles as they do not cause discomfort to patients during body movements 114
TABLE 39 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR CANNULAS, BY COUNTRY, 2020–2027 (USD MILLION) 114
6.3.2.5 Tubing & extension sets 115
6.3.2.5.1 Tubing & extension sets are used to provide a consistent connection between a patient’s body and the infusion pump 115
TABLE 40 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR TUBING & EXTENSION SETS, BY COUNTRY, 2020–2027 (USD MILLION) 116
6.3.2.6 Valves 116
6.3.2.6.1 Valves are used to regulate the flow of infusion fluids 116
TABLE 41 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VALVES, BY COUNTRY, 2020–2027 (USD MILLION) 117
6.3.2.7 Other Non-dedicated accessories and consumables 117
TABLE 42 OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 118
6.4 DEVICES 118
6.4.1 DEVICES MARKET, BY PRODUCT 119
TABLE 43 APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 119
TABLE 44 APAC INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 119
6.4.1.1 Volumetric infusion pumps 120
6.4.1.1.1 Wide range of applications for volumetric infusion pumps to drive the market growth 120
TABLE 45 VOLUMETRIC INFUSION PUMPS AVAILABLE IN THE MARKET 120
TABLE 46 APAC VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 121
6.4.1.2 Insulin pumps 121
6.4.1.2.1 Growing demand for smart insulin pumps and portable insulin pumps in homecare settings to drive the market growth 121
TABLE 47 INSULIN PUMPS AVAILABLE IN THE MARKET 122
TABLE 48 APAC INSULIN PUMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
6.4.1.3 Ambulatory infusion pumps 123
TABLE 49 AMBULATORY INFUSION PUMPS AVAILABLE IN THE MARKET 123
TABLE 50 APAC AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 124
TABLE 51 APAC AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 124
6.4.1.3.1 Disposable infusion pumps 124
6.4.1.3.1.1 Disposable infusion pumps are mainly used in homecare settings and pediatric departments 124
TABLE 52 DISPOSABLE INFUSION PUMPS AVAILABLE IN THE MARKET 125
TABLE 53 APAC DISPOSABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 125
6.4.1.3.2 Chemotherapy infusion pumps 125
6.4.1.3.2.1 These pumps administer continuous infusion to cancer patients in homecare settings 125
TABLE 54 CHEMOTHERAPY INFUSION PUMPS AVAILABLE IN THE MARKET 126
TABLE 55 APAC CHEMOTHERAPY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 126
6.4.1.4 Syringe infusion pumps 126
6.4.1.4.1 Syringe infusion pumps are used to deliver a lower volume of fluids at a low flow rate 126
TABLE 56 SYRINGE INFUSION PUMPS AVAILABLE IN THE MARKET 127
TABLE 57 APAC SYRINGE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 127
6.4.1.5 Enteral infusion pumps 128
6.4.1.5.1 Enteral infusion pumps are designed to deliver nutrients and medicines into a patient’s digestive tract 128
TABLE 58 ENTERAL INFUSION PUMPS AVAILABLE IN THE MARKET 128
TABLE 59 APAC ENTERAL INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 129
6.4.1.6 PCA pumps 129
6.4.1.6.1 Growth in this segment is driven by the rising preference for effective pain management therapies 129
TABLE 60 PCA PUMPS AVAILABLE IN THE MARKET 129
TABLE 61 APAC PCA PUMPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.4.1.7 Implantable infusion pumps 130
6.4.1.7.1 High costs of implantable infusion pump therapies and procedures to restrict the segment growth 130
TABLE 62 IMPLANTABLE INFUSION PUMPS AVAILABLE IN THE MARKET 131
TABLE 63 APAC IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 131
6.4.2 DEVICES MARKET, BY TECHNOLOGY 131
TABLE 64 APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 131
6.4.2.1 Traditional infusion pumps 132
6.4.2.1.1 Wide applications of traditional infusion pumps due to low costs to drive the segment growth 132
TABLE 65 APAC TRADITIONAL INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 132
6.4.2.2 Specialty infusion pumps 132
6.4.2.2.1 Technological advancements & the rising adoption of specialty infusion pumps in homecare settings supports segment growth 132
TABLE 66 APAC SPECIALTY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 133
6.4.3 DEVICES MARKET, BY TYPE 133
TABLE 67 APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
6.4.3.1 Stationary infusion pumps 134
6.4.3.1.1 High adoption of stationary infusion pumps in hospitals to drive the market growth 134
TABLE 68 APAC STATIONARY INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 134
6.4.3.2 Portable infusion pumps 134
6.4.3.2.1 Technological advancements in portable infusion pumps to drive the growth of this segment 134
TABLE 69 APAC PORTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 135
7 APAC INFUSION PUMPS MARKET, BY APPLICATION 136
7.1 INTRODUCTION 137
TABLE 70 APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 137
7.2 CHEMOTHERAPY/ONCOLOGY 138
7.2.1 THE DEMAND FOR INFUSION PUMPS FOR CHEMOTHERAPY IS MAINLY DRIVEN BY THE GROWING INCIDENCE OF CANCER 138
FIGURE 31 ASIA PACIFIC: ESTIMATED NUMBER OF NEW CANCER CASES, BY REGION, 2020–2040 138
TABLE 71 APAC INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 139
7.3 DIABETES MANAGEMENT 139
7.3.1 THE RISING PREVALENCE OF DIABETES HAS INCREASED THE DEMAND FOR ACCESSIBLE & EFFECTIVE DIABETES MANAGEMENT—A KEY FACTOR DRIVING THE MARKET GROWTH 139
FIGURE 32 ASIA PACIFIC: DIABETES INCIDENCE, BY REGION, 2015–2045 140
TABLE 72 APAC INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT,
BY COUNTRY, 2020–2027(USD MILLION) 141
7.4 GASTROENTEROLOGY 142
7.4.1 DOCTORS PREFER TREATING PATIENTS WITH SEVERE DIGESTIVE SYSTEM DISORDERS BY USING INFUSION PUMPS TO DELIVER DRUGS INTO THE SYSTEM 142
TABLE 73 DISEASES & DISORDERS OF THE DIGESTIVE SYSTEM 142
TABLE 74 APAC INFUSION PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2020–2027(USD MILLION) 143
7.5 ANALGESIA/PAIN MANAGEMENT 144
7.5.1 THE RISING NUMBER OF SURGICAL PROCEDURES PROPEL THE MARKET GROWTH OF THIS SEGMENT 144
TABLE 75 ASIA PACIFIC: CHRONIC PAIN STATISTICS, 2018 144
TABLE 76 APAC INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT,
BY COUNTRY, 2020–2027(USD MILLION) 145
7.6 PEDIATRICS/NEONATOLOGY 145
7.6.1 INCREASING INCIDENCE OF PRETERM BIRTHS AND NEWBORN DEATHS DRIVE THE UPTAKE OF INFUSION PUMPS IN THIS SEGMENT 145
TABLE 77 ASIAN COUNTRIES WITH THE HIGHEST NUMBER OF PRETERM BIRTHS (2018) 146
TABLE 78 ASIAN COUNTRIES WITH THE HIGHEST NUMBER OF NEWBORN DEATHS (2020) 146
TABLE 79 APAC INFUSION PUMPS MARKET FOR PEDIATRICS/NEONATOLOGY,
BY COUNTRY, 2020–2027(USD MILLION) 147
7.7 HEMATOLOGY 147
7.7.1 INCREASING PREVALENCE OF BLOOD DISORDERS TO SUPPORT THE GROWTH OF THIS SEGMENT 147
TABLE 80 ASIA PACIFIC: PREVALENCE OF ANEMIA IN WOMEN OF REPRODUCTIVE AGE (15–49 YEARS) (% OF THE POPULATION), BY COUNTRY 148
TABLE 81 APAC INFUSION PUMPS MARKET FOR HEMATOLOGY, BY COUNTRY,
2020–2027(USD MILLION) 148
7.8 OTHER APPLICATIONS 149
TABLE 82 APAC INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027(USD MILLION) 149
8 APAC INFUSION PUMPS MARKET, BY END USER 150
8.1 INTRODUCTION 151
TABLE 83 APAC INFUSION PUMPS MARKET, BY END USER, 2020–2027 (USD MILLION) 151
8.2 HOSPITALS 151
8.2.1 STRONG PURCHASING POWER BY HOSPITALS FOR HIGH-PRICED INFUSION PUMPS TO DRIVE THE MARKET GROWTH 151
TABLE 84 NUMBER OF HOSPITALS, BY COUNTRY, 2010–2020 152
TABLE 85 APAC INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY,
2020–2027 (USD MILLION) 153
8.3 HOMECARE SETTINGS 153
8.3.1 PATIENTS ARE INCREASINGLY OPTING TO GET TREATED AT HOME—
A KEY FACTOR DRIVING MARKET GROWTH 153
TABLE 86 APAC INFUSION PUMPS MARKET FOR HOMECARE SETTINGS, BY COUNTRY, 2020–2027(USD MILLION) 154
8.4 AMBULATORY CARE SETTINGS 154
8.4.1 GROWING NUMBER OF SURGICAL PROCEDURES PERFORMED IN ASCS TO DRIVE THE MARKET GROWTH 154
TABLE 87 APAC INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS,
BY COUNTRY, 2020–2027(USD MILLION) 155
8.5 ACADEMIC & RESEARCH INSTITUTES 156
8.5.1 INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT THE GROWTH OF THIS SEGMENT 156
TABLE 88 INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2020–2027(USD MILLION) 156
9 APAC INFUSION PUMPS MARKET, BY COUNTRY 157
9.1 INTRODUCTION 158
FIGURE 33 APAC: NUMBER OF CRITICAL BEDS PER 100,000 PEOPLE 159
FIGURE 34 ASIA PACIFIC: INFUSION PUMPS MARKET SNAPSHOT 160
TABLE 89 APAC INFUSION PUMPS MARKET, BY COUNTRY, 2020–2027(USD MILLION) 161
9.2 COVID-19 IMPACT ON THE APAC INFUSION PUMPS MARKET 161
9.2.1 CHINA 162
9.2.1.1 Growing investments in healthcare infrastructure development in China to drive the market growth 162
TABLE 90 KEY MACRO INDICATORS FOR CHINA 163
TABLE 91 CHINA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 163
TABLE 92 CHINA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 163
TABLE 93 CHINA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 164
TABLE 94 CHINA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 164
TABLE 95 CHINA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 165
TABLE 96 CHINA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 165
TABLE 97 CHINA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION) 165
TABLE 98 CHINA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 166
TABLE 99 CHINA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 166
TABLE 100 CHINA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 166
9.2.2 JAPAN 167
9.2.2.1 The extensive geriatric population in Japan is expected to drive the subsequent demand for infusion pumps & devices 167
TABLE 101 KEY MACRO INDICATORS FOR JAPAN 167
TABLE 102 JAPAN: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 168
TABLE 103 JAPAN: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 168
TABLE 104 JAPAN: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 168
TABLE 105 JAPAN: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 169
TABLE 106 JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 169
TABLE 107 JAPAN: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 170
TABLE 108 JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION) 170
TABLE 109 JAPAN: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 170
TABLE 110 JAPAN: AAPC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 171
TABLE 111 JAPAN: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 171
9.2.3 INDIA 171
9.2.3.1 The high prevalence of lifestyle diseases drives the market growth for infusion pumps in India 171
TABLE 112 KEY MACRO INDICATORS FOR INDIA 172
TABLE 113 INDIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 173
TABLE 114 INDIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 173
TABLE 115 INDIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 173
TABLE 116 INDIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 174
TABLE 117 INDIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 174
TABLE 118 INDIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 175
TABLE 119 INDIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION) 175
TABLE 120 INDIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 175
TABLE 121 INDIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 176
TABLE 122 INDIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 176
9.2.4 AUSTRALIA 176
9.2.4.1 The high prevalence of chronic diseases in the country supports the market growth 176
TABLE 123 KEY MACRO INDICATORS FOR AUSTRALIA 177
TABLE 124 AUSTRALIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 177
TABLE 125 AUSTRALIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 178
TABLE 126 AUSTRALIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 178
TABLE 127 AUSTRALIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 179
TABLE 128 AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 179
TABLE 129 AUSTRALIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 180
TABLE 130 AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027(USD MILLION) 180
TABLE 131 AUSTRALIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 180
TABLE 132 AUSTRALIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 181
TABLE 133 AUSTRALIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 181
9.2.5 THAILAND 181
9.2.5.1 The rising prevalence of cancer supports the market growth for infusion pumps in Thailand 181
TABLE 134 KEY MACRO INDICATORS FOR THAILAND 182
TABLE 135 THAILAND: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 182
TABLE 136 THAILAND: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 183
TABLE 137 THAILAND: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 183
TABLE 138 THAILAND: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 184
TABLE 139 THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 184
TABLE 140 THAILAND: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 185
TABLE 141 THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027(USD MILLION) 185
TABLE 142 THAILAND: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 185
TABLE 143 THAILAND: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 186
TABLE 144 THAILAND: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 186
9.2.6 INDONESIA 186
9.2.6.1 The rising prevalence of cancer supports the market for infusion pumps in Indonesia 186
TABLE 145 KEY MACRO INDICATORS FOR INDONESIA 187
TABLE 146 INDONESIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 187
TABLE 147 INDONESIA: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 148 INDONESIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 149 INDONESIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 150 INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 189
TABLE 151 INDONESIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 152 INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 190
TABLE 153 INDONESIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 190
TABLE 154 INDONESIA: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 191
TABLE 155 INDONESIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027 (USD MILLION) 191
9.2.7 VIETNAM 191
9.2.7.1 The high incidence of preterm births in the country has propelled the growth of the infusion pumps market 191
TABLE 156 KEY MACRO INDICATORS FOR VIETNAM 192
TABLE 157 VIETNAM: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 192
TABLE 158 VIETNAM: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 159 VIETNAM: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 160 VIETNAM: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 161 VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 194
TABLE 162 VIETNAM: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 195
TABLE 163 VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 195
TABLE 164 VIETNAM: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 195
TABLE 165 VIETNAM: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 196
TABLE 166 VIETNAM: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027 (USD MILLION) 196
9.2.8 SOUTHEAST ASIA 196
9.2.8.1 Growth in medical tourism in the SEA countries to drive the market for infusion pumps 196
FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2019 197
TABLE 167 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND) 197
FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2019) 197
FIGURE 37 GERIATRIC POPULATION IN 2020 (% OF TOTAL POPULATION) 198
TABLE 168 SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 198
TABLE 169 SOUTHEAST ASIA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 198
TABLE 170 SOUTHEAST ASIA: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 199
TABLE 171 SOUTHEAST ASIA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 199
TABLE 172 SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT, 2020–2027(USD MILLION) 200
TABLE 173 SOUTHEAST ASIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2020–2027(USD MILLION) 200
TABLE 174 SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET,
BY TECHNOLOGY, 2020–2027(USD MILLION) 200
TABLE 175 SOUTHEAST ASIA: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 201
TABLE 176 SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY APPLICATION, 2020–2027(USD MILLION) 201
TABLE 177 SOUTHEAST ASIA: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 202
9.2.9 REST OF ASIA PACIFIC (ROAPAC) 202
FIGURE 38 ESTIMATED NUMBER OF CANCER CASES IN REST OF APAC COUNTRIES, 2020 VS. 2040 (IN THOUSAND) 203
TABLE 178 ROAPAC: APAC INFUSION PUMPS MARKET, BY PRODUCT,
2020–2027(USD MILLION) 203
TABLE 179 ROAPAC: APAC INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 203
TABLE 180 ROAPAC: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2020–2027(USD MILLION) 204
TABLE 181 ROAPAC: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2020–2027(USD MILLION) 204
TABLE 182 ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2020–2027(USD MILLION) 205
TABLE 183 ROAPAC: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2020–2027(USD MILLION) 205
TABLE 184 ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2020–2027(USD MILLION) 205
TABLE 185 ROAPAC: APAC INFUSION PUMP DEVICES MARKET, BY TYPE,
2020–2027(USD MILLION) 206
TABLE 186 ROAPAC: APAC INFUSION PUMPS MARKET, BY APPLICATION,
2020–2027(USD MILLION) 206
TABLE 187 ROAPAC: APAC INFUSION PUMPS MARKET, BY SETTING,
2020–2027(USD MILLION) 206
10 COMPETITIVE LANDSCAPE 207
10.1 OVERVIEW 207
FIGURE 39 KEY PLAYER STRATEGIES 208
10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 209
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE APAC INFUSION PUMPS MARKET 209
10.3 MARKET SHARE ANALYSIS 210
FIGURE 41 APAC INFUSION PUMPS MARKET SHARE BY KEY PLAYER, 2021 210
TABLE 188 APAC INFUSION PUMPS MARKET: DEGREE OF COMPETITION 211
10.4 COMPANY EVALUATION QUADRANT 213
10.4.1 STARS 213
10.4.2 EMERGING LEADERS 213
10.4.3 PERVASIVE PLAYERS 213
10.4.4 PARTICIPANTS 213
FIGURE 42 INFUSION PUMPS MARKET: COMPANY EVALUATION QUADRANT (2021) 214
10.5 COMPANY FOOTPRINTS 215
TABLE 189 FOOTPRINT OF COMPANIES IN THE APAC INFUSION PUMPS MARKET 215
TABLE 190 PRODUCT PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET 216
TABLE 191 APPLICATION PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET 218
TABLE 192 END USER PORTFOLIO ANALYSIS: APAC INFUSION PUMPS MARKET 219
10.6 COMPETITIVE SCENARIO 220
10.6.1 PRODUCT LAUNCHES 220
TABLE 193 PRODUCT LAUNCHES (JANUARY 2018 – FEBRUARY 2022) 220
10.6.2 DEALS 221
TABLE 194 DEALS (JANUARY 2018–FEBRUARY 2022) 221
10.6.3 OTHER DEVELOPMENTS 222
TABLE 195 OTHER DEVELOPMENTS (JANUARY 2018– FEBRUARY 2022) 222"
"11 COMPANY PROFILES 223
11.1 KEY PLAYERS 223
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 BECTON, DICKINSON AND COMPANY 223
TABLE 196 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 223
FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021) 224
11.1.2 B. BRAUN MELSUNGEN AG 228
TABLE 197 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 228
FIGURE 44 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021) 229
11.1.3 FRESENIUS KABI AG 236
TABLE 198 FRESENIUS KABI: BUSINESS OVERVIEW 236
FIGURE 45 FRESENIUS KABI AG: COMPANY SNAPSHOT (2021) 237
11.1.4 BAXTER INTERNATIONAL INC. 241
TABLE 199 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 241
FIGURE 46 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2021) 242
11.1.5 MEDTRONIC PLC 245
TABLE 200 MEDTRONIC PLC: BUSINESS OVERVIEW 245
FIGURE 47 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 246
11.1.6 ICU MEDICAL, INC. 250
TABLE 201 ICU MEDICAL: BUSINESS OVERVIEW 250
FIGURE 48 ICU MEDICAL: COMPANY SNAPSHOT (2021) 251
11.1.7 AVANOS MEDICAL, INC. 255
TABLE 202 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW 255
FIGURE 49 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2021) 256
11.1.8 TERUMO CORPORATION 258
TABLE 203 TERUMO CORPORATION: BUSINESS OVERVIEW 258
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2020) 259
11.1.9 NIPRO CORPORATION 261
TABLE 204 NIPRO CORPORATION: BUSINESS OVERVIEW 261
FIGURE 51 NIPRO CORPORATION: COMPANY SNAPSHOT (2021) 262
11.1.10 JMS CO., LTD. 265
TABLE 205 JMS CO., LTD.: BUSINESS OVERVIEW 265
FIGURE 52 JMS CO., LTD.: COMPANY SNAPSHOT (2021) 266
11.1.11 CARDINAL HEALTH, INC. 268
TABLE 206 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 268
FIGURE 53 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021) 269
11.1.12 EPIC MEDICAL 271
TABLE 207 EPIC MEDICAL: BUSINESS OVERVIEW 271
11.1.13 F. HOFFMANN-LA ROCHE LTD. 273
TABLE 208 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 273
FIGURE 54 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021) 274
11.1.14 ABBOTT LABORATORIES 276
TABLE 209 ABBOTT LABORATORIES: BUSINESS OVERVIEW 276
FIGURE 55 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 277
11.1.15 DANAHER CORPORATION 278
TABLE 210 DANAHER CORPORATION: BUSINESS OVERVIEW 278
FIGURE 56 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 279
11.2 OTHER PLAYERS 281
11.2.1 MINDRAY MEDICAL INTERNATIONAL LIMITED 281
TABLE 211 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 281
11.2.2 SOOIL DEVELOPMENT CO., LTD. 283
TABLE 212 SOOIL DEVELOPMENT CO., LTD.: BUSINESS OVERVIEW 283
11.2.3 MICREL MEDICAL DEVICES SA 284
TABLE 213 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW 284
11.2.4 TANDEM DIABETES CARE, INC. 286
TABLE 214 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW 286
FIGURE 57 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2021) 287
11.2.5 YPSOMED HOLDING AG 289
TABLE 215 YPSOMED HOLDING AG: BUSINESS OVERVIEW 289
FIGURE 58 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2020) 290
11.2.6 SHENZHEN MEDRENA BIOTECH CO., LTD. 292
TABLE 216 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW 292
11.2.7 ALLIED MEDICAL LIMITED 293
TABLE 217 ALLIED MEDICAL LIMITED: BUSINESS OVERVIEW 293
11.2.8 BPL MEDICAL TECHNOLOGIES 294
TABLE 218 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 294
11.2.9 SHANGHAI LEIEN MEDICAL EQUIPMENT CO., LTD. 295
TABLE 219 SHANGHAI LEIEN MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 295
11.2.10 PLENUM TECH LIMITED 296
TABLE 220 PLENUM TECH LIMITED: BUSINESS OVERVIEW 296
11.3 LIST OF DISTRIBUTORS AND SUPPLIERS IN THE APAC REGION 297
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 298
12.1 INSIGHTS FROM INDUSTRY EXPERTS 298
12.2 DISCUSSION GUIDE 299
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 304
12.4 AVAILABLE CUSTOMIZATIONS 306
12.5 RELATED REPORTS 306
12.6 AUTHOR DETAILS 308"
US $
Euro €
GBP £